Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yong Ke

Showing results (191-200 of 194) with videos related to

Pageof 20
Sort By:
You have reached the last page of results.This site can display upto 194 results.
American Journal of Hematology|August 31, 2018
Multicenter randomized trial of arsenic trioxide and Realgar-Indigo naturalis formula in pediatric patients with acute promyelocytic leukemia: Interim results of the SCCLG-APL clinical studyMing-Hua Yang, Wu-Qing Wan, Jie-Si Luo, et al.
Acta Pharmacologica Sinica|January 28, 2023
Long-term passaging of pseudo-typed SARS-CoV-2 reveals the breadth of monoclonal and bispecific antibody cocktailsHang Ma, Hui-Fang Zong, Jun-Jun Liu, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 5, 2025
Rapid restoration of potent neutralization activity against the latest Omicron variant JN.1 via AI rational design and antibody engineeringYunji Liao, Hang Ma, Zhenyu Wang, et al.
Cell Discovery|February 16, 2022
Broad ultra-potent neutralization of SARS-CoV-2 variants by monoclonal antibodies specific to the tip of RBDHang Ma, Yingying Guo, Haoneng Tang, et al.
Pageof 20

Showing results (191-200 of 194) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 194 results.
American Journal of Hematology|August 31, 2018
Multicenter randomized trial of arsenic trioxide and Realgar-Indigo naturalis formula in pediatric patients with acute promyelocytic leukemia: Interim results of the SCCLG-APL clinical studyMing-Hua Yang, Wu-Qing Wan, Jie-Si Luo, et al.
Acta Pharmacologica Sinica|January 28, 2023
Long-term passaging of pseudo-typed SARS-CoV-2 reveals the breadth of monoclonal and bispecific antibody cocktailsHang Ma, Hui-Fang Zong, Jun-Jun Liu, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 5, 2025
Rapid restoration of potent neutralization activity against the latest Omicron variant JN.1 via AI rational design and antibody engineeringYunji Liao, Hang Ma, Zhenyu Wang, et al.
Cell Discovery|February 16, 2022
Broad ultra-potent neutralization of SARS-CoV-2 variants by monoclonal antibodies specific to the tip of RBDHang Ma, Yingying Guo, Haoneng Tang, et al.
Pageof 20